Associated Papers
TIAM1 variants improve clinical outcome in neuroblastoma.
Sanmartín E et al.
Oncotarget, 2017
28423360 (PubMed )
Supplement: oncotarget-08-45286-s004.xlsx › Sheet1
Molecular context of the EGFR mutations: evidence for the activation of mTOR/S6K signaling.
Conde E et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2006
Select a paper to view details